Programa de pesquisa em produtos naturais: a experiência da CEME

The Brazilian effort on R&D of products from the national biodiversity dates back to the 70's. The Central de Medicamentos - CEME - was tailored to add scientific and technological competence to the production of pharmaceutical drugs derived from the Brazilian biodiversity by means of the Research Programme on Medicinal Plants - PPPM. Although previous to the Convention on Biological Diversity - CBD - and to the current debate and the ever-growing interest on phytomedicines, CEME has historical importance in the present governmental efforts on fostering the R&D on phytomedicines. This article makes a historical redemption of the PPPM, the actions and the results in the course of its existence.